We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.74B
AUM Growth
+$109M
Cap. Flow
-$39.8M
Cap. Flow %
-1.07%
Top 10 Hldgs %
14.14%
Holding
1,395
New
97
Increased
557
Reduced
530
Closed
105

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$13.6M
2
OZK icon
Bank OZK
OZK
+$5.04M
3
J icon
Jacobs Solutions
J
+$4.45M
4
CNI icon
Canadian National Railway
CNI
+$3.34M
5
CELG
Celgene Corp
CELG
+$3.33M

Top Sells

Rank Stock Value
1
DD
Du Pont De Nemours E I
DD
+$13.5M
2
AMC icon
AMC Entertainment Holdings
AMC
+$6.18M
3
AMGN icon
Amgen
AMGN
+$5.53M
4
CCOI icon
Cogent Communications
CCOI
+$5.13M
5
ORLY icon
O'Reilly Automotive
ORLY
+$5.07M

Sector Composition

Rank Sector Weight
1 Healthcare 13.61%
2 Financials 11.8%
3 Technology 10.96%
4 Industrials 9.65%
5 Consumer Discretionary 8.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NBR icon
1251
Nabors Industries
NBR
$1.22B
$90K ﹤0.01%
+224
New +$82K
ALLT icon
1252
Allot
ALLT
$367M
$87K ﹤0.01%
16,100
– –
BAC.WS.B
1253
DELISTED
Bank Of America Corporation Ws B
BAC.WS.B
$87K ﹤0.01%
110,700
-4,000
-3% -$2.93K
TCRT icon
1254
Alaunos Therapeutics
TCRT
$4.59M
$86K ﹤0.01%
93
-27
-23% -$24K
BKEP
1255
DELISTED
Blueknight Energy Partners L.P.
BKEP
$86K ﹤0.01%
15,000
– –
AG icon
1256
First Majestic Silver
AG
$7.75B
$83K ﹤0.01%
+12,160
New +$87.1K
MIN
1257
Aberdeen Intermediate Income Fund
MIN
$273M
$75K ﹤0.01%
17,600
-42,400
-71% -$182K
TPST icon
1258
Tempest Therapeutics
TPST
$13.8M
$72K ﹤0.01%
18
+4
+29% +$17.1K
ATCO
1259
DELISTED
Atlas Corp.
ATCO
$71K ﹤0.01%
+10,000
New +$68.8K
RMGN
1260
DELISTED
RMG Networks Holding Corporation
RMGN
$70K ﹤0.01%
32,624
– –
CHK
1261
DELISTED
Chesapeake Energy Corporation
CHK
$68K ﹤0.01%
79
-41
-34% -$35.2K
TNXP icon
1262
Tonix Pharmaceuticals
TNXP
$161M
– –
0
– –
XNET
1263
Xunlei
XNET
$360M
$60K ﹤0.01%
14,000
– –
SCU
1264
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$52K ﹤0.01%
1,600
– –
JCP
1265
DELISTED
J.C. Penney Company, Inc.
JCP
$52K ﹤0.01%
13,600
-10,000
-42% -$44.3K
PDLI
1266
DELISTED
PDL BioPharma, Inc.
PDLI
$51K ﹤0.01%
15,188
– –
CCIH
1267
DELISTED
Chinacache International Holdings Ltd
CCIH
$51K ﹤0.01%
59,737
-912
-2% -$779
GGB icon
1268
Gerdau
GGB
$9.74B
$48K ﹤0.01%
17,640
– –
VSTM icon
1269
Verastem
VSTM
$536M
$48K ﹤0.01%
843
-9
-1% -$425
AXAS
1270
DELISTED
Abraxas Petroleum Corp
AXAS
$48K ﹤0.01%
1,275
-500
-28% -$17K
OIG
1271
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$42K ﹤0.01%
282
– –
NGD
1272
DELISTED
New Gold Inc
NGD
$41K ﹤0.01%
11,118
– –
BNBX
1273
DELISTED
BNB PLUS CORP
BNBX
– –
0
– –
LITS
1274
Lite Strategy Inc
LITS
$33.6M
$30K ﹤0.01%
+555
New +$30.8K
ARQL
1275
DELISTED
Arqule Inc
ARQL
$29K ﹤0.01%
26,000
– –
49 50
51
52 53

Similar funds

LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
AIM
Allen Investment Management New York $8.09B AUM 16.78% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Oppenheimer & Co's Q3 2017 Portfolio in Review

As of Q3 2017, Oppenheimer & Co held 1,395 positions worth $3.74B, up 3% from $3.63B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q3 2017 filing shows 97 new, 557 increased, 530 reduced and 105 closed positions. Its largest new stake was Jacobs Solutions: 99,458 shares worth $4.79M. The largest sale was Du Pont De Nemours E I, an estimated $13.5M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Financials and Technology.

  • Oppenheimer & Co's largest Q3 2017 buy was Jacobs Solutions: 99,458 shares worth $4.79M.
  • Oppenheimer & Co added most to DuPont de Nemours in Q3 2017, an estimated $13.6M increase.
  • Oppenheimer & Co's biggest Q3 2017 reduction was Amgen, cutting an estimated $5.53M.
  • Oppenheimer & Co fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $13.5M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.74B portfolio in Q3 2017.
  • Oppenheimer & Co opened 97 new positions and closed 105 in Q3 2017.
  • Oppenheimer & Co's portfolio value rose 3% quarter-over-quarter to $3.74B.

Based on Oppenheimer & Co's 13F filing for Q3 2017, filed 9 Nov 2017.